Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ÌìÃÀ´«Ã½ Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Paracentral acute middle maculopathy (PAMM) is a condition impacting retinal blood flow characterized by ischemia affecting the deep capillary plexus often
resulting in permanent blind spots. PAMM has been reported in association with retinal vascular diseases, and there is currently no acceptable treatment for PAMM.
We report a case in which a patient experienced numerous episodes of blind spots over multiple years and was left with permanent blind spots in each eye. We
prescribed OTC oral niacin based upon multiple reviews of the literature of different organ systems, which worked on numerous challenges in our patient, reversing
his recurrent blind spots. In reviewing the literature, we concluded that the retinal blood flow is affected by niacin as it acts as a potent vasodilator. We reviewed
numerous papers on other therapeutic benefits of niacin products, which has been proven to be beneficial for the brain and optic nerve based upon perfusion
pressure and increased blood flow in small vessels. The loss of vision in patients with vascular dementia is a multifactorial issue resulting from decreased blood flow
of the brain, optic nerve, retinal ganglion cells, and the occipital lobe. We hypothesize that oral niacin ER OTC taken at a safe dosage of 500 mg given once daily at
bedtime, can be used a preventative drug for blindness in patients with vascular dementia, given its proven ability to open venous blood outflow from the brain and
optic nerve. We promote the use of niacin ER because niacin can last for over 24 hours at a safe dose. Furthermore, niacin ER (vitamin B3) can be taken without
prescription as a dietary supplement, which is safe, inexpensive, and can also help to prevent further deterioration of patients� brains with vascular dementia.
Biography
Jason Sendek has worked closely with his mentor, Dr. Robert Josephberg, they are researching the potential for new therapeutic modalities for eye disease, their key objective of this research is to inform other physicians of these innovative approaches and he has been an attending physician at Westchester Medical Center for over 30 years, as well as the Chief of Retina Service for over 20 years. He is currently a senior at Briarcliff High School in Westchester County, NY and will be attending Duke University starting in the fall of 2022.
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, ÌìÃÀ´«Ã½ Access Journals